老龄化的社会、不断发展的延长生命的医疗干预、老年医保政策和个体决策的伦理,共同造就了美国日益严重的社会紧张:一方面要控制医保费用,一方面又要促进健康消费者使用生命维持技术。这些制造长寿的活动,就像许多其他的社会医疗实践一样,构成了生命管理以及新的伦理态度和社会参与的一个场所。这些活动——包括处理风险的必要性、对于循证干预的难以言“不”以及在临床条件下做出选择的义务——也处于卫生资源配给和改革的论争中心。心脏手术、器官移植和癌症治疗是三个延长生命的医学成功的范例,同时也是产生存在困境和社会困境之标志。医学人类学的视角彰显了生命制造与医疗支出之关联,也揭示了基于年龄配给医疗资源的持续的讨论。 Aging societies, ever-evolving life-extending medical interventions, old-age health insurance policies and the ethics of individual decision-making have all contributed to the growing social tensions in the United States: on the one hand, the cost of health care should be controlled and on the other hand, healthy life should be promoted Maintain technology. These longevity-creating activities, like many other social medical practices, form a place for life-management and new ethical attitudes and social engagement. These activities, including the need to address risks, the implausible “no” evidence-based interventions and the obligation to make choices under clinical conditions, are also at the center of controversy over the rationing and reform of health resources. Cardiac surgery, organ transplantation and cancer treatment are examples of three life-long medical successes and are also hallmarks of the dilemmas and social dilemmas. The perspective of medical anthropology highlights the link between life-manufacturing and health care expenditures, as well as the ongoing discussion of the rationing of medical resources based on age.